# Clopidogrel Pharmacogenetics (PGX) Bench to Bedside

> **NCT01341600** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 18 (actual)

## Conditions studied

- Metabolism of Clopidogrel

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Omeprazole/Clopidogrel

## Key facts

- **NCT ID:** NCT01341600
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341600, "Clopidogrel Pharmacogenetics (PGX) Bench to Bedside". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01341600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*